Vestal Point Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26M Buy
550,000
+350,000
+175% +$16.5M 1.37% 24
2025
Q1
$7.81M Buy
+200,000
New +$7.81M 0.56% 39